Cell4Pharma and InnoSer forge partnership to drive integrated preclinical drug screening
Cell4Pharma and InnoSer are proud to announce a strategic partnership aimed at offering integrated preclinical drug screening services. This collaboration combines Cell4Pharma’s expertise in vitro kidney screening assays and vesicular transport assays with InnoSer’s pioneering preclinical research services.
Together, they aim to accelerate the progression of preclinical candidates, bringing them closer to impactful drug discovery and development.
Find more news here.


